HESI RN
Reproductive Health Exam Questions And Answers
1. What is the estimated percentage of deaths due to unsafe abortions from 591 maternal deaths per 100,000 live births?
- A. 0.1
- B. 0.2
- C. 0.3
- D. 0.4
Correct answer: D
Rationale: To calculate the estimated percentage of deaths due to unsafe abortions, you divide the number of deaths due to unsafe abortions by the total number of maternal deaths and then multiply by 100 to get the percentage. In this case, with 591 maternal deaths and 40% estimated to be due to unsafe abortions, the calculation is (591 * 0.4) / 100, which equals 2.36. Therefore, the estimated percentage of deaths due to unsafe abortions from 591 maternal deaths per 100,000 live births is 0.4 or 40%. Choices A, B, and C are incorrect percentages that do not reflect the provided information.
2. In Primary Health care, the concept of accessibility requires that:
- A. Patients should be required to accept one service in order to gain access to another type of service.
- B. A referral network, including transportation, to higher-level facilities should be coupled to PHC services.
- C. Patients' access to services should be contingent on social or cultural backgrounds, age, and marital status.
- D. Patients' access to services should be based on one's educational status.
Correct answer: B
Rationale: In Primary Health care, accessibility entails having a referral network and transportation system in place to link patients to higher-level facilities when needed. Choice A is incorrect because patients should not be required to accept one service to access another. Choice C is incorrect as access to services should not be contingent on social or cultural backgrounds, age, or marital status. Choice D is also incorrect because educational status should not determine patients' access to healthcare services.
3. What is the primary use of Bromocriptine?
- A. Relieve constriction ring.
- B. Manage post-partum hemorrhage.
- C. Affect milk production.
- D. Be used in pre-eclampsia.
Correct answer: C
Rationale: Bromocriptine is primarily used to affect milk production. It is a medication commonly prescribed to help suppress lactation, particularly in cases of postpartum breast engorgement or when stopping breastfeeding. Choices A, B, and D are incorrect as Bromocriptine is not indicated for relieving constriction ring, managing post-partum hemorrhage, or treating pre-eclampsia.
4. At what point is a fetus considered viable?
- A. 26 weeks
- B. 28 weeks
- C. 37 weeks
- D. 12 weeks
Correct answer: C
Rationale: A fetus is considered viable after 37 weeks of gestation. At this stage, the fetus has a higher chance of surviving outside the womb with medical support. Choice A (26 weeks), Choice B (28 weeks), and Choice D (12 weeks) are incorrect because a fetus is not typically considered viable at those earlier gestational ages.
5. What is the role of the corpus luteum during the menstrual cycle?
- A. The corpus luteum produces estrogen to maintain the endometrium.
- B. The corpus luteum produces progesterone to maintain the endometrium.
- C. The corpus luteum produces testosterone to inhibit ovulation.
- D. The corpus luteum has no significant role during the menstrual cycle.
Correct answer: B
Rationale: The correct answer is B: The corpus luteum produces progesterone to maintain the endometrium during the menstrual cycle. This hormone helps prepare the uterine lining for implantation in case fertilization occurs. Choice A is incorrect because estrogen is mainly produced by the developing follicles in the ovaries. Choice C is incorrect as testosterone is produced in smaller amounts by the ovaries and adrenal glands but does not play a significant role in maintaining the endometrium. Choice D is incorrect as the corpus luteum plays a crucial role in producing progesterone to support the endometrium.
Similar Questions
Access More Features
HESI RN Basic
$89/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access